Wednesday , March 29 2017
Home / Press Releases

Press Releases

Specialty Pharma Journal Launches its Rebranded Logo and Website

Specialty Pharma Journal (SPJ) today announced the launch of its new name, Specialty Precision & Technology Pharma Journal, along with a rebranding initiative which includes a new logo and website. The change reflects the publication’s focus on “precision medicine,” a new healthcare model that uses innovative technologies to tailor treatment …

Read More »

NICE Recommends Use of Pfizer’s Inlyta in Kidney Cancer and Rejects Dendreon’s Provenge for Prostate Cancer

The National Institute for Health and Care Excellence (NICE) issued two final guidelines, recommending Pfizer’s Inlyta (axitinib) in kidney cancer, but rejecting Dendreon’s Provenge (sipuleucel-T) in prostate cancer. In guidance issued to the NHS, the drug pricing watchdog recommended Inlyta as a second-line option for treating adults with advanced renal …

Read More »

Specialty Pharma Journal (SPJ) and Specialty Pharma Education Center (SPEC) Partner for Business-Based Educational Programs in Specialty Pharmacy

Tampa, FL, February 24, 2015 — Specialty Pharma Journal (SPJ) announced today that it has partnered with the Specialty Pharma Education Center (SPEC) to bring business-based educational programs to the specialty pharmacy industry. SPJ and SPEC are developing programs dedicated to education in biosimilars, 340B contracting, co-pay and coupon adjudication guidelines in …

Read More »

CMS Issues Proposed Payment and Policy Changes for 2016 Medicare Health and Drug Plans

The Centers for Medicare & Medicaid Services (CMS) released its annual guidance to Medicare drug plan sponsors, for proposed changes for 2016 payment and policy updates. The agency said that the proposed changes for the coming year for the Medicare Advantage (MA) and Part D Prescription Drug Programs advances an …

Read More »

New Affordable Care Act Initiative Aims to Improve Cancer Care and Cut Costs

Today, the US Department of Health and Human Services (HHS) announced a cancer care initiative for Medicare beneficiaries that will link payments to oncology practices to quality of care and patient outcomes. The New Affordable Care Act initiative, by the Centers for Medicare and Medicaid Services (CMS), is in support …

Read More »

Ignyta’s Lung Cancer Drug Receives Orphan Drug Status from the FDA

Today, precision oncology biotechnology company Ignyta, Inc. announced that its lead candidate has been granted orphan drug designation from US health regulators. According to the company, the US Food and Drug Administration (FDA) granted Ignyta’s entrectinib orphan drug designation for the treatment of TrkA-positive, TrkB-positive, TrkC-positive, ROS1-positive and ALK-positive non-small …

Read More »

Physician’s Offices and Clinics Remain Largest Customer Base for Specialty Rx Distributors

Center Research Highlights Latest Trends for Fast-Growing Specialty Market Segment ARLINGTON, Va., February 3, 2015 — Physician’s offices and independently owned and operated physician clinics remain the largest customer base for specialty pharmaceutical distributors, at 63 percent of their sales value, according to the2014 Specialty Pharmaceutical Distribution: Facts, Figures and …

Read More »

White House Provides Details for Obama’s $215 Million Precision Medicine Initiative

Following up on President Barack Obama’s announcement in his State of the Union Address, the Administration unveiled details about the Precision Medicine Initiative, including plans to collect genetic data on one million Americans. On Friday, Obama gave more details about the initiative that he originally announced during his State of …

Read More »